Gregory K. Bergey, MD, is professor of neurology at The Johns Hopkins University School of Medicine in Baltimore, Maryland, where he is also director of The Johns Hopkins Epilepsy Center, vice chair for Neurological Laboratories, and co-director of the Epilepsy Research Laboratory. He is a member of the Epilepsy Foundation Research Council, the National Institutes of Health (NIH) NST Training and Career Development Study Section, and has served on the Board of Directors of the American Epilepsy Society (AES) and other NIH study sections. In addition to serving as a reviewer for a number of journals, Dr. Bergey is chief editor, clinical science, Epilepsy Currents. He has been involved in numerous clinical trials of investigational treatments for epilepsy, and the NIH-funded research projects he participates in at the Epilepsy Research Laboratory involve patterns of seizure onset, propagation and cessation of seizures, and investigations into computer-simulated neural networks. His clinical interests are intractable epilepsy, primary generalized seizure disorders, and epilepsy in special populations.

 
  

Amy R. Brooks-Kayal, MD, is professor of pediatrics, University of Colorado, Denver School of Medicine, and director of child neurology, The Children’s Hospital, Denver. Dr. Brooks-Kayal’s research focuses on the effects of early-life seizure activity on the development of neurotransmitter systems in the immature brain. Her work has particular emphasis on the role of GABAA receptors in development and epileptogenesis, a topic on which she lectures extensively and has been widely published. An active member of several professional and scientific societies, Dr. Brooks-Kayal is a member of the Board of Directors for the AES and served as the chair of the Scientific Program Committee in 2005. She has also served as a member of multiple other AES committees and as a member of the NIH Clinical Neurosciences and Disease study section. Dr. Brooks-Kayal serves on the program committee for the Society for Neuroscience and was on the organizing committee for the NIH Curing Epilepsy 2007 Conference. She also is associate editor of developmental and pediatric epilepsy content for Epilepsia.
 
   Jacqueline A. French, MD, is a professor in the Department of Neurology, and member of the New York University Comprehensive Epilepsy Center. Dr. French trained in neurology at Mount Sinai Hospital in New York and completed her fellowship training in electroencephalogram (EEG) and epilepsy at Mount Sinai Hospital and Yale University. Dr. French has focused her research efforts on the development of new therapeutics for epilepsy and is the co-director of a biannual symposium on trial design and its implications. She has written many articles, editorials, and chapters and has edited 2 books on the subject. Dr. French has also been active in creating practice parameters, serving on committees of the American Academy of Neurology and the AES, and chairing several practice parameter task forces. She has served on the board of the AES and the American Society of Experimental Therapeutics and is the 2005 recipient of the AES Service Award. Dr. French is the head of the scientific advisory board of the Epilepsy Therapy Development Project, a private group devoted to the development of new epilepsy therapies, and serves as co-chair of the International League Against Epilepsy Commission on Therapeutic Strategies. Dr. French is the director of the Epilepsy Study Consortium.
 
   Gregory L. Holmes, MD, is professor of neurology and pediatrics and chairman of neurology at Dartmouth Medical School in Hanover, New Hampshire. He is widely published as a researcher focusing on the delineation, effects, and treatment of pediatric/developmental epilepsy. In addition to being active in professional society and hospital committees, Dr. Holmes has served on the editorial boards of 8 epilepsy journals, has been in multiple NIH study sections, and has lectured internationally at hospitals, medical schools, and major epilepsy and neurology associations. He also serves as a doctor for Camp Wee-Kan-Tu, a camp for children with epilepsy in Massachusetts.
 
  

Ilo E. Leppik, MD, is director of research of MINCEP Epilepsy Care in Minneapolis and professor of pharmacy and adjunct professor of neurology at the University of Minnesota. Dr. Leppik is the past president of the AES and the past chairman of the AES Guidelines Task Force and the Central Society for Neurological Research. He was the founding and managing editor of Epilepsy Research from 1986-2006. He also was on the board of directors of the Epilepsy Foundation of America and chaired its professional advisory board. Currently, Dr. Leppik is principal investigator of a multicenter study of epilepsy in the elderly. His research is widely published, and he has authored or coauthored a number of books, including Contemporary Diagnosis and Management of the Patient With Epilepsy. He is the recipient of the 2007 William G. Lennox Award from the AES.
 
   Michael D. Privitera, MD, is professor of neurology and director of the Cincinnati Epilepsy Center at the University of Cincinnati Medical Center in Ohio. During his fellowship in epilepsy and EEG at the University of Texas Southwestern Medical School, he was awarded the Wilder Penfield Research Award from the AES for his work with antiepileptic drug pharmacology. He is the treasurer elect of the AES. Dr. Privitera has coauthored many scientific publications in the area of epilepsy. He recently authored a book, Clinician’s Guide to Antiepileptic Drug Use. Dr. Privitera is the recipient of several NIH contracts and has been a principal investigator or investigator for more than 30 different protocols for the study of investigational antiepileptic drugs.